iDerm Pharma is a company headquartered in Israel.
iDerm Pharma is a biotechnology company developing a first-in-class oral small molecule therapy targeting autoimmune inflammatory skin diseases such as psoriasis.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.